A Study of the Safety, Dosing, and Delivery of NEO100 in Patients With Pediatric Brain Tumors

Clinical trial NCT06357377 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06357377
Sponsor: Neonc Technologies, Inc.
Status: NOT_YET_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Pediatric Tumor of CNS Pediatric Tumor of Brain Diffuse Midline Glioma, H3 K27M-Mutant Pediatric Tumor of Brain Stem Pineocytoma Choroid Plexus Carcinoma, Childhood Spinal Cord Tumor High Grade Glioma

Start date: 2026-01-01
Primary completion: 2026-10-01
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.